Global pharma supply-chain services are a ‘$77bn profit pool’ amid looming patent cliffs Recently in Preqin First Close, we explored private equity and VC’s growing focus on the fast-progressing biopharma supply-chain services industry. Here, we take a second look at some big activity in the space. Nobody wants to get old or sick. Demand for […]




















